Senseonics Holdings, Inc. (SENS)

0.5181 +0.0556 (+12.02%) 收市：04:00PM EDT

Senseonics Holdings, Inc.

20451 Seneca Meadows Parkway
Germantown, MD 20876-7005
United States
301 515 7260
https://www.senseonics.com

版塊: Healthcare
行業: Medical Devices
全職員工: 132

高階主管

名稱	頭銜	支付	行使價	出生年份
Dr. Timothy T. Goodnow Ph.D.	President, CEO & Director	1.28M	無	1962
Dr. Mukul Jain Ph.D.	Chief Operating Officer	769.17k	無	1973
Mr. Kenneth L. Horton	General Counsel & Corporate Development Advisor	737.28k	無	1967
Mr. Frederick T. Sullivan	CFO, Secretary & Treasurer	無	無	1982
Dr. Francine Ratner Kaufman M.D.	Chief Medical Officer & Director	無	無	1951

截止 2023年12月31日為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。

描述

Senseonics Holdings, Inc., a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.

公司管治

截至 2024年5月1日 止，Senseonics Holdings, Inc. 的 ISS 管治質素評分為 10。 Pillar 分數正在審核中：8；董事會：8；股東權利：8；現金賠償：10。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。